IL1B and rheumatoid arthritis: In addition, the percentage of IL-1β+ RA PBMCs decreased from 3.31 (SD ± 0.375) in untreated cells to 2.75 (SD ± 0.558) in PBMCs treated for 48 h with PE-EVOOs.